Patent · US Active

Extended GLP-1 compounds

US8603972B2 · kind B2 · utility

9Cited by
3References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 20, 2006
Grant dateDec 10, 2013
Priority date
Expiry dateDec 11, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to protracted GLP-1 compounds and therapeutic uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.